Your browser doesn't support javascript.
loading
Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial.
Elgohary, Mohamed Abdel-Salam; Hasan, Eman Medhat; Ibrahim, Amany Ahmad; Abdelsalam, Mohamed Farouk Ahmed; Abdel-Rahman, Raafat Zaher; Zaki, Ashraf Ibrahim; Elaatar, Mohamed Bakr; Elnagar, Mohamed Thabet; Emam, Mohamed Emam; Hamada, Mahmoud Moustafa; Abdel-Hamid, Taimour Mohamed; Abdel-Hafez, Ahmad Samir; Seadawy, Mohamed Gomaa; Fatoh, Ahmad Rashad; Elsaied, Mohamed Ali; Sakr, Marwa Abdel-Rahman; Elkady, Ahmed Omar; Shehata, Mohamed Muawad; Nawar, Osama Mohamed; Selem, Mohamed Abu-Elnaga; Abd-Aal, Mohamed Saeed; Lotfy, Hany Hafez; Elnagdy, Tarek Refaat; Helmy, Sherine; Mubark, Magdy Amin.
Afiliación
  • Elgohary MA; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Hasan EM; Tropical Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Ibrahim AA; Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Abdelsalam MFA; Clinical Pharmacy Department, Al Galaa Military Medical Complex (GMMC), Cairo, Egypt.
  • Abdel-Rahman RZ; Virology Department, Central Military Laboratories, Cairo, Egypt.
  • Zaki AI; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Elaatar MB; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Elnagar MT; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Emam ME; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Hamada MM; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Abdel-Hamid TM; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Abdel-Hafez AS; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Seadawy MG; Biological Prevention Department, Egyptian Army, Cairo, Egypt.
  • Fatoh AR; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Elsaied MA; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Sakr MA; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Elkady AO; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Shehata MM; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Nawar OM; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Selem MA; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Abd-Aal MS; COVID Isolation Department, Almaza Fever Hospital, Cairo, Egypt.
  • Lotfy HH; Radiology Department, Military Medical Academy, Cairo, Egypt.
  • Elnagdy TR; Egyptian Military Medical Services Department, Egyptian Army, Cairo, Egypt.
  • Helmy S; Research & Development, PHARCO Pharmaceuticals, Alexandria, Egypt.
  • Mubark MA; Egyptian Military Medical Services Department, Egyptian Army, Cairo, Egypt.
J Med Life ; 15(3): 350-358, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35449996
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 4_covid_19 / 4_hepatitis / 6_digestive_diseases Asunto principal: Hepatitis C / Hepatitis C Crónica / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Med Life Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Egipto
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 4_covid_19 / 4_hepatitis / 6_digestive_diseases Asunto principal: Hepatitis C / Hepatitis C Crónica / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Med Life Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Egipto